Funded Startups in Cambridge, Massachusetts

DeepkinetiX Inc. is a pioneering company dedicated to revolutionizing the drug development landscape through the innovative application of artificial intelligence and computational modeling techniques. By employing advanced technologies, they strive to optimize pharmacokinetic and pharmacodynamic processes, fostering speed and precision in drug analysis.

Founded 2024

Epicore Biosystems, Inc. is a digital health company that develops and markets wearable microfluidic technology for real-time, non-invasive health and wellness monitoring. Their solutions provide insights into hydration, stress, nutrition, and overall physiological state, enabling personalized health management.

Ernexa Therapeutics Inc. is a biotechnology company focused on developing cell therapy solutions for advanced cancer and autoimmune diseases. They use induced pluripotent stem cells (iPSCs) to create induced mesenchymal stem cells (iMSCs) with unique targeting capabilities, enabling the creation of scalable, off-the-shelf therapies. This method eliminates the need for patient-specific solutions.

Filter Labs, Inc. specializes in delivering high-quality, location-specific data solutions, addressing the acute need for accurate local intelligence in regions typically underserved by traditional information sources. Their innovative approach utilizes advanced filtering technology to provide insights into local communities, enabling global decision-makers to make informed decisions based on up-to-date and actionable data.

Founded 2022

MacroCycle Technologies is dedicated to addressing crucial environmental challenges in the plastics industry by providing innovative circular economy and zero carbon technologies. The company focuses on sustainable plastic waste management and reducing carbon emissions associated with plastic production.

Founded 2023

Nanopath Inc is a pioneering molecular diagnostics company headquartered in Cambridge, Massachusetts. The company is dedicated to revolutionizing traditional medical testing approaches, particularly in the domain of women's health, by developing rapid and accurate diagnostic solutions.

Neutrolis Inc. is a clinical-stage biotechnology firm that specializes in developing innovative therapies aimed at autoimmune and inflammatory diseases. The company's unique approach focuses on targeting Neutrophil Extracellular Traps (NETs), which are implicated in tissue damage and chronic inflammation associated with several immune-mediated disorders, such as lupus and dry eye disease, as well as severe complications from conditions like COVID-19.

Vaxess Technologies, Inc. is a pioneering life sciences company focused on the development of innovative vaccine and therapeutic delivery technologies. Their flagship product, the MIMIX™ platform, is a cutting-edge transdermal patch system that aims to make vaccines and therapeutics more effective and accessible, particularly in challenging environments.